top of page
Browse by category
Search


FDA approves Soleno’s VYKAT XR to treat hyperphagia in Prader-Willi Syndrome
The FDA has approved Soleno Therapeutics’ VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the...


Soleno reveals positive results from DCCR for Prader-Willi Syndrome
Soleno Therapeutics has announced positive top-line results from the randomised withdrawal period of Study C602, a long-term treatment...
Browse by tag





bottom of page